Related Experiment Videos
Neurotoxicity of Adriamycin and misonidazole in the mouse
Abstract:
The neurotoxicity of the anticancer drug adriamycin was investigated in the peripheral nerve of the mouse. Injection of adriamycin into the sciatic nerve resulted in biochemical and morphologic signs of severe axonal degeneration. The biochemical evidence was based on marked increases in lysosomal enzyme activity. Acid protease and N-acetylglucosaminidase remained elevated for more than 70 days after injecting the drug. In contrast, local injection of the radiation-sensitizing drug misonidazole into the peripheral nerve failed to increase lysosomal enzyme activity.
Insights
Adriamycin causes severe peripheral nerve damage, indicated by increased lysosomal enzymes in mouse sciatic nerves. This neurotoxicity, marked by elevated acid protease and N-acetylglucosaminidase, persisted for over 70 days.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- Adriamycin is a widely used chemotherapy agent.
- Peripheral neuropathy is a known side effect of some chemotherapies.
- The specific mechanisms of adriamycin-induced peripheral neurotoxicity require further elucidation.
Purpose of the Study:
- To investigate the neurotoxic effects of adriamycin on the peripheral nerve.
- To assess the biochemical and morphological changes in the sciatic nerve following adriamycin injection.
- To compare the effects of adriamycin with misonidazole on peripheral nerve lysosomal enzyme activity.
Main Methods:
- Adriamycin was injected into the sciatic nerve of mice.
- Lysosomal enzyme activity (acid protease, N-acetylglucosaminidase) was measured.
- Morphological assessment of axonal degeneration was performed.
- Misonidazole was injected into the sciatic nerve as a control.
Main Results:
- Adriamycin injection led to significant axonal degeneration in the sciatic nerve.
- Marked increases in lysosomal enzyme activity, specifically acid protease and N-acetylglucosaminidase, were observed.
- Elevated enzyme levels persisted for over 70 days post-injection.
- Misonidazole injection did not alter lysosomal enzyme activity.
Conclusions:
- Adriamycin induces severe neurotoxicity in the peripheral nerve.
- Increased lysosomal enzyme activity is a key biochemical marker of adriamycin-induced axonal damage.
- The observed neurotoxicity is specific to adriamycin and not a general effect of drug injection in the nerve.